MARGARET ROLFE: Open Payments
NPI 1386340065 · DAYVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 49 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 13 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $116 |
| Novo Nordisk Inc | 4 | $94 |
| Phathom Pharmaceuticals, Inc. | 3 | $86 |
| Ardelyx, Inc. | 4 | $85 |
| ABBVIE INC. | 3 | $73 |
| PFIZER INC. | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Exact Sciences Corporation | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
Products named: RECORLEV, Kerendia, ELIQUIS, VOQUEZNA, IBSRELA, JARDIANCE, Ozempic, Cologuard Collection Kit.
Industry payments across CT — which companies pay providers there.
